13K
$1B
602$50M$100M
87K$1B
1$10M
6K$1B
201$50M$100M
1.1K$100M$1BEvofem Biosciences uses 8 technology products and services including Cloudflare, Google Font API, Cloudflare Bot Management, and more. Explore Evofem Biosciences's tech stack below.
| Evofem Biosciences Email Formats | Percentage |
| FLast@evofem.com | 95% |
| Last@evofem.com | 3% |
| First@evofem.com | 1% |
| FirstL@evofem.com | 1% |
Biotechnology ResearchCalifornia, United States51-200 Employees
Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health In September 2020, Evofem launched Phexxi, the first and only hormone-free, on-demand, prescription birth control available in the U.S. that women use only when they have sex.
Company Overview
Funding & FinancialsEvofem Biosciences has raised a total of $35M of funding over 2 rounds. Their latest funding round was raised on Aug 03, 2016 in the amount of $25Mas a Series D.
Evofem Biosciences's revenue is in the range of $10M$50M
Funding & FinancialsEvofem Biosciences has raised a total of $35M of funding over 2 rounds. Their latest funding round was raised on Aug 03, 2016 in the amount of $25Mas a Series D.
Evofem Biosciences's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com